• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Free fatty acid receptor 2 promotes cardiomyocyte hypertrophy by activating STAT3 and GATA4

    2022-11-28 13:19:26HuiGoKunmingTinXiojunFengMengqingYnChenGoYishengJingChenhoZhuHuzheZhuXuepingLiuYingfuPeng

    Hui Go*, Kunming Tin, Xiojun Feng, Mengqing Yn, Chen Go,Yisheng Jing, Chenho Zhu, Huzhe Zhu, Xueping Liu*, Yingfu Peng*

    a Department of Pharmacology, School of Medicine, Shaoxing University, Shaoxing 312000, China

    b Department of Pharmacology, School of Medicine, Jishou University, Jishou 416000, China

    c Department of Environmental Toxicity, Zunyi Medical University, Zunyi 563006, China

    d The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230002, China

    e Department of Pharmacology, School of Medicine, GuangXi University of science and Technology, Liuzhou 545006, China

    Keywords:

    FFA2

    Cardiac hypertrophy

    GATA4

    STAT3

    ERK1/2

    A B S T R A C T

    Free fatty acids (FFAs) play important roles in cardiovascular disease. Studies have shown that it is an important way for FAs to exert biological effects through their own receptors besides directly participating biochemical reaction in body. Free fatty acid receptor 2 (FFA2) can be activated by short-chain FAs and is involved in inflammatory reactions and lipid accumulation. Since the known pathological changes caused by FFA2 are also implicated in cardiac hypertrophy, we hypothesized that FFA2 might be pathogenic in cardiac hypertrophy. This paper showed that FFA2 expression significantly increased in cardiac hypertrophy in vivo and in vitro. FFA2 agonist 4-CMTB or TUG-1375 promoted the expression of the hypertrophy markers ANF and BNP and increased cell surface area in vitro, which was further strengthened by FFA2 overexpression,suggesting that FFA2 might contribute to cardiomyocyte hypertrophy. Furthermore, 4-CMTB treatment or FFA2 overexpression combined with 4-CMTB treatment elevated the phosphorylation and transcriptional activity of GATA4 and STAT3, which were inhibited by an ERK1/2 inhibitor, and GATA4 and STAT3 knockdown inhibited the elevation of hypertrophy biomarkers in cardiomyocytes treated with 4-CMTB. Taken together, these data indicate that FFA2 can enhance cardiomyocyte hypertrophy by activating STAT3 and GATA4 via ERK1/2, providing a potential new target for therapy.

    1. Introduction

    Cardiac hypertrophy describes adaptive changes in the heart caused by pressure overload, which is characterized by cardiomyocyte hypertrophy and interstitial fibrosis [1]. However,when hypertrophied, the heart is susceptible to ischemia caused by the increased ventricular wall thickness and diastolic dysfunction caused by fibrosis. Moreover, the systolic function of the heart is gradually impaired during disease progression, ultimately resulting in heart failure.

    Continuous activation of the sympathetic nervous system and the renin-angiotensin system play important roles in cardiac hypertrophy [1-4], and current drugs that improve outcomes for patients with cardiac hypertrophy or heart failure usually inhibit these two systems [2-4]. However, clinical outcomes are still unsatisfactory with these current therapies, and new drugs for cardiac hypertrophy are still needed.

    The role of fatty acids in cardiovascular disease such as atherosclerosis and cardiac hypertrophy has received increasing attention [5]. Interestingly, some studies have found that fatty acids not only participate in biochemical reactions in the body, but also function through their own receptors, free fatty acid (FFA) receptors [6-8].

    All FFA receptors are members of G protein-coupled receptors and mainly include FFA1 (GPR40), FFA2 (GPR43), FFA3 (GPR41)and FFA4 (GPR120); their natural ligands are FFAs with different carbon chain lengths [9,10]. FFA2 is 331 amino acid residues long and can be activated by short-chain fatty acids such as acetate, butyrate,and propionate. FFA2 is mainly expressed in the gastrointestinal tract,adipose tissue, immune cells, spleen, skeletal muscle, brain, etc., and there is a moderate expression in heart [11,12]. Previous studies have shown that FFA2 is associated with inflammatory reactions [13-15]and lipid accumulation [12], which play vital roles in cardiac hypertrophy. Moreover, FFA2 can couple with Gq/11and Giproteins,both of which may be related to cardiac hypertrophy: FFA2 reduces cAMP production through Gito regulate adenylate cyclase [9,10,13-15],which might impair cardiac contraction. Furthermore, FFA2 can elevate intracellular Ca2+and activate protein kinase C (PKC) and the mitogen-activated protein kinase (MAPK) cascade by activating Gq/11[16,17], and these changes are also closely related to cardiac hypertrophy [18,19].

    ERK1/2-MAPK is a downstream effector of FFA2 [16,17];furthermore, some transcription factors such as GATA4 and STAT3 can be activated by ERK1/2, which play important roles in cardiac hypertrophy [20,21]. So FFA2 might promote the transcription of hypertrophic genes and protein synthesis to induce cardiomyocyte hypertrophy by activating STAT3 and GATA4.

    2. Materials and methods

    2.1 Chemicals and antibodies

    4-CMTB (4642) was purchased from Tocris Bioscience (Bristol,UK). TUG-1375 was purchased from Target Molecule Corp.(Boston, MA, USA). Phenylephrine (PE, P6126) was obtained from Sigma Aldrich (St. Louis, MO, USA). U0126 (9903), rabbit monoclonal anti-p-MAPK-Erk1/2 (Thr202/Tyr204) (1:2 000; 4 370),rabbit monoclonal anti-p-STAT3 (Tyr705) (1:1 000; 9145), rabbit polyclonal anti-p-STAT3 (Ser727) (1:1 000; 9134), and mouse monoclonal anti-STAT3 (1:1 000; 9139) were purchased from Cell Signaling Technology (CST, Danvers, MA, USA). Isoproterenol(sc-202188), angiotensin II (sc-363643), rabbit polyclonal anti-FFA2 (1:100; sc-32906), mouse monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (1:200; GAPDH, sc-365062), mouse monoclonal anti-GATA4 (1:100; sc-25310), and mouse monoclonal anti-phospho-GATA4 (Ser262) (1:100; sc-377543) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Rabbit polyclonal anti-p-GATA4 (Ser105)(1:1 000; ab5245) was purchased from Abcam (Cambridge, UK).

    2.2 Animal model of cardiac hypertrophy

    Sprague-Dawley rats (male, 180-200 g) obtained from Hunan SJA Laboratory Animal Co., Ltd. (Changsha, China) were randomly divided into two groups: sham operation group (Sham) and abdominal aortic constriction (AAC) group. AAC surgery was performed to induce pressure overload as described previously [22]. Eight weeks after the operation, all rats were anaesthetized and then sacrificed for further experiments. All experimental procedures were conducted in conformity with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and approved by the Animal Care and Studies Committee of Jishou University (Jishou, China).

    2.3 Primary culture of neonatal rat cardiomyocytes (NRCMs)

    Primary cultures of NRCMs were prepared as described previously [23]. In brief, the chopped heart tissues of 1-2-day-old Sprague-Dawley rats were repeatedly digested with 0.08% trypsin at 37 °C for 10-12 times. The cells were collected by centrifugation at 800 r/min and re-suspended in DMEM with 10% newborn calf serum (NBCS). The cells were then incubated in culture flasks for 1 h at 37 °C in a humidified atmosphere with 5% CO2to remove adherent non-cardiomyocytes. The purified cardiomyocytes were cultured in DMEM supplemented with 10% NBCS and 0.1 mmol/L 5-bromodeoxyuridine for 16-24 h in 6-well plates (1.0 × 105cells/mL).Finally, the culture medium was replaced with fresh DMEM containing 10% NBCS. Before each experiment, cells were placed in serum-free medium for 16-18 h.

    2.4 RNA extraction and quantitative RT-PCR

    Total RNA was extracted using Trizol reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. Total RNA was reverse transcribed to first-strand cDNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific). cDNA was amplified using KOD SYBR?qPCR Mix (Toyobo, Japan) in a real-time PCR machine (LightCycler,Roche, Penzberg, Germany). The primer sequences were were listed as follows: FFA2 (F: 5’-CCCGGTGCAGTACAAGCTAT-3’,R: 5’-C T G C T C G G T T G A G T T C A G G T-3’), A N F(F: 5’-C C G T A T A C A G T G C G G T G T C C-3’, R:5’-C A G A G A G G G A G C T A A G T G C C-3’), B N P(F: 5’-A G C T G C T T T G G G C A G A A G A T-3’, R:5’-AAAACAACCTCAGCCCGTCA-3’) and GAPDH(F: 5’-A G G A G T A A G A A A C C C T G G A C-3’, R:5’-CTGGGATGGAATTGTGAG-3’). Each PCR reaction was performed in triplicate. Data are presented as fold change over control group.

    2.5 RNA interference and plasmid transfection

    Cardiomyocytes were transfected with 2.5 μg FFA2 plasmid using 5 μL Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) in six-well plates according to the manufacturer’s instructions. ThepcDNA3.1-flag vector was used as a control. After transfection for 48 h, cells were harvested.

    Cardiomyocytes were transfected either with GATA4 siRNA or STAT3 siRNA with non-targeting siRNA (negative control,NC) using Lipofectamine 3000 according to the manufacturer’s instructions. siRNA sequences were: GATA4 siRNA (5’-CUUC AGAGCCGACAGCACUGGAUGG-3’) [24]and STAT3 siRNA(5’-GGCAUUCGGAAAGUAUUGUTT-3’) [25].

    2.6 Western blotting

    Cultured cardiomyocytes or cardiac tissues were homogenized in RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China)supplemented with protease inhibitor cocktail (sc-29130, Santa Cruz Biotechnology). The mixture was incubated on ice for 30 min and then centrifuged at 12 000 ×gfor 10 min at 4 °C and the total protein collected. Proteins were separated in 10% SDS–PAGE and were then transferred to PVDF membranes (Millipore, Burlington, MA,USA). Membranes were blocked with 5% bovine serum albumin and then incubated with primary antibodies overnight at 4 °C and secondary antibodies (1:5 000; Santa Cruz Biotechnology) for 1 h at room temperature. Blots were developed with an enhanced chemiluminescence substrate (Beyotime Biotechnology) and detected with the Minichemi 420 (Sage Creation Science Co., Ltd., Beijing,China). Blot intensities were quantified with the Image J software.

    2.7 Measurement of the cell surface area

    The cell surface area was determined by rhodamine-phalloidin staining as previously described [23]. Cardiomyocyte surface area (40 randomly chosen fields and 100 randomly chosen cells/field) was determined by Cellomics/High Content Screening (Thermo Fisher Scientific).

    2.8 Dual luciferase reporter gene assay

    ThepGATA4-TA-lucreporter plasmid, which contains the 2 600 bp 5’-flanking region of the ratANFgene, was constructed as described previously [26]. For the dual luciferase reporter assay,cardiomyocytes were seeded in 96-well culture plates and cotransfected with 100 ng ofpSTAT3-TA-lucreporter plasmid (Beyotime Biotechnology) orpGATA4-TA-lucreporter plasmid and 20 ng ofpRL-TKplasmid (Promega, Madison, WI, USA) using Lipofectamine 3 000 based on the manufacturer’s instructions. After 48 h, cells were lysed, and luciferase activity was determined using the dual luciferase reporter assay kit (Beyotime Biotechnology) according to the manufacturer’s recommendations. Luciferase activity was normalized to Renilla luciferase activity.

    2.9 Statistical analysis

    Data are expressed as mean ± S.D. Statistical analyses were performed using the unpaired Student’st-test or analysis of variance (ANOVA) followed by Bonferronipost hoctesting using SPSS 20.0 (IBM Statistics, Chicago, IL).P< 0.05 was considered statistically significant.

    3. Results

    3.1 FFA2 expression is elevated in cardiac hypertrophy

    AAC surgery was performed to induce cardiac hypertrophy in the rats. Compared with Sham rats, AAC rats had bigger hearts, thicker left ventricular walls, larger cardiomyocyte diameters (Fig. 1A), and higher heart-to-body weight ratios (Fig. 1B), indicating successful induction of cardiac hypertrophy. As shown Figs. 1C and 1D,compared to Sham rats, cardiac FFA2mRNA and protein expression were significantly increased in AAC rats.

    Next, NRCMs were treated with phenylephrine (PE), isoproterenol(ISO), or angiotensin II (Ang II) to induce cardiomyocyte hypertrophyin vitro. Gene expression of atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) (Fig. 2A) and the cell surface area(Fig. 2B) increased in cardiomyocytes treated with PE, ISO, or Ang II. ANF and BNP, which are secreted by atrial myocytes and ventricular myocytes respectively, rise in cardiac hypertrophy and are considered as important hypertrophic markers nowadays [1]. FFA2 mRNA (Fig. 2C) and protein (Fig. 2D) expression also increased after the treatments. Thus, FFA2 might play an important role in cardiac hypertrophy.

    Fig. 1 FFA2 expression increases in cardiac hypertrophy induced by AAC in rats. Rats underwent AAC or Sham surgery for 8 weeks. (A) H&E staining of transverse sections of hearts; scale bar = 50 μm; (B) heart-to-body weight ratio (HW/BW); (C) mRNA and (D) protein expression of FFA2 were detected by RT-PCR or western blotting, respectively. *P < 0.05 versus Sham.

    Fig. 2 FFA2 expression increases in cardiomyocyte hypertrophy induced by PE, ISO, or Ang II treatment in vitro. NRCMs were treated with or without PE(100 μmol/L), ISO (10 μmol/L), or Ang II (10 μmol/L) for 24 h. (A) mRNA expression of ANF and BNP was detected by RT-PCR (n = 4 independent experiments); (B) cell surface area was measured by phalloidin staining (n = 4 independent experiments); scale bar = 10 μm; (C) mRNA and(D) protein expression of FFA2 were detected by RT-PCR or western blotting, respectively (n = 5 independent experiments). *P < 0.05 versus Con.

    3.2 FFA2 promotes cardiomyocyte hypertrophy

    The increased expression of FFA2 might be associated with the development of cardiac hypertrophy. 4-CMTB, which is widely accepted as a specific FFA2 agonist that not only binds to both the orthosteric and the allosteric binding sites [27]but also activates Gqand Giproteins [17,28], or FFA2 overexpression to investigate the role of FFA2 in cardiomyocyte hypertrophy. As shown in Fig. 3, compared to control,ANFandBNPexpression and cell surface area increased in NRCMs treated with 4-CMTB. Compared to 4-CMTB treatment,these increases were even more obvious in FFA2-overexpressed NRCMs with 4-CMTB treatment (Figs. 3B and 3C). Moreover, the knockdown of FFA2 completely abolished the hypertrophic response in 4-CMTB-treated cardiomyocytes (Fig. 4), which indicated that it was a specific agonist for FFA2. To further enhance the reliability of our research, another FFA2 agonist, TUG-1375 [29]was used in this study. Similar results were obtained in cardiomyocytes treated with TUG-1375 (Figs. 3D and 3E). These results indicate that FFA2 can promote cardiomyocyte hypertrophy.

    Fig. 3 FFA2 promotes cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1- flag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) or TUG-1375 (10 μmol/L) for 24 h. (A) FFA2 protein expression was detected by western blotting; (B and D) mRNA levels of ANF and BNP were measured by RT-PCR; (C and E) cell surface area was measured by phalloidin staining; scale bar = 10 μm. *P < 0.05 versus pcDNA3.1,#P < 0.05 versus 4-CMTB or TUG-1375.

    Fig. 4 FFA2 knockdown inhibits cardiomyocyte hypertrophy induced by 4-CMTB. NRCMs were transfected with siRNA targeting FFA2 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for 24 h. (A) The expressions of FFA2 and p-ERK1/2 protein were detected by western blotting; (B) mRNA levels of ANF and BNP were measured by RT-PCR; (C) cell surface area was measured by phalloidin staining; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    3.3 GATA4 and STAT3 are involved in FFA2-induced cardiomyocyte hypertrophy

    Increased transcriptional activity of GATA4 plays a key role in cardiac hypertrophy, so we next studied the effects of GATA4 in FFA2-induced cardiomyocyte hypertrophy. Compared with control,4-CMTB treatment elevated GATA4 phosphorylation at Ser105(Fig. 5A) and GATA4 transcriptional activity (Fig. 5B) by western blotting and luciferase reporter assays, respectively, which were further increased inFFA2- flag plasmid-transfected cardiomyocytes.However, GATA4 phosphorylation at Ser262 was not altered by 4-CMTB treatment (Fig. 5A). In order to investigate whether GATA4 acts as a downstream signaling molecule of FFA2 in cardiomyocyte hypertrophy, we knocked downGATA4expression in cardiomyocytes treated with 4-CMTB (Fig. 5C). Compared to 4-CMTB treatment,GATA4knockdown significantly decreasedANFandBNPmRNA levels as well as cell surface area in cardiomyocytes stimulated with 4-CMTB, which might therefore inhibit cardiomyocyte hypertrophy(Figs. 5D and 5E).

    Fig. 5 GATA4 activation is involved in FFA2-induced cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1- flag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (A) GATA4 phosphorylation at Ser105 and Ser262 as well as total GATA4 expression were detected by western blotting; (B) the transcriptional activity of GATA4 was measured using a luciferase reporter assay. *P < 0.05 versus pcDNA3.1, #P < 0.05 versus 4-CMTB. To investigate the role of GATA4 in FFA2-induced cardiomyocyte hypertrophy, NRCMs were transfected with siRNA targeting GATA4 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (C) Western blotting was used to evaluate the silencing efficacy of siRNA targeting GATA4; (D) ANF and BNP mRNA levels as well as (E) cell surface area were measured to assess the hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    STAT3 is another important transcription factor involved in cardiac hypertrophy. We found that STAT3 phosphorylation at Tyr705 and Ser727 (Fig. 6A) as well as its transcriptional activity(Fig. 6B) were elevated by 4-CMTB compared to control, and these changes were more obvious in 4-CMTB-treated cardiomyocytes after transfection withFFA2- flag plasmid (Figs. 6A and 6B). To investigate the role of STAT3 as a downstream signaling molecule of FFA2 in cardiomyocyte hypertrophy, we knocked downSTAT3expression in cardiomyocytes treated with 4-CMTB (Fig. 6C). Compared to 4-CMTB treatment alone,STAT3knockdown significantly decreasedANFandBNPmRNA expression as well as cell surface area in cardiomyocytes stimulated with 4-CMTB (Figs. 6D and 6E), thereby inhibiting cardiomyocyte hypertrophy.

    Fig. 6 STAT3 activation is involved in FFA2-induced cardiomyocyte hypertrophy. NRCMs were transfected with pcDNA3.1-FFA2- flag plasmid or pcDNA3.1-lf ag for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (A) NRCMs were transfected with FFA2- flag plasmid or pcDNA3.1 for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. STAT3 phosphorylation at Tyr705 and Ser727 as well as total STAT3 expression were detected by western blotting; (B) the transcriptional activity of STAT3 was measured using a luciferase reporter assay. *P < 0.05 versus vector, #P < 0.05 versus 4-CMTB. To investigate the role of STAT3 in FFA2-induced cardiomyocyte hypertrophy, NRCMs were transfected with siRNA targeting STAT3 or NC for 24 h and then stimulated with or without 4-CMTB (10 μmol/L) for another 24 h. (C) Western blotting was used to evaluate the silencing efficacy of siRNA targeting STAT3; (D) ANF and BNP mRNA expression as well as (E) cell surface area were measured to assess hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus NC, #P < 0.05 versus 4-CMTB.

    ERK1/2 can promote the phosphorylation of GATA4 at Ser105 and STAT3 at Ser727 [20,21]. U0126, a MAPK-ERK1/2 pathway inhibitor [30](Fig. 7A), reduced GATA4 phosphorylation at Ser105(Fig. 7B) as well as GATA4 transcriptional activity (Fig. 7C)in cardiomyocytes treated with 4-CMTB. In addition, STAT3 phosphorylation at Ser727 (Fig. 7D) as well as its transcriptional activity (Fig. 7E) were also inhibited by U0126. Furthermore,increases inANFandBNPmRNA expression as well as cell surface area induced by 4-CMTB treatment were also reduced by U0126 treatment (Figs. 7F and 7G). Similar results were observed in cardiomyocytes treated with TUG-1375 (Fig. 8).

    Fig. 7 The effects of 4-CMTB on GATA4 and STAT3 function as well as cardiomyocyte hypertrophy are impaired by MAPK-ERK1/2 pathway inhibition.NRCMs were stimulated with or without 4-CMTB (10 μmol/L) and simultaneously treated with or without U0126 (10 μmol/L) for 24 h. (A) p-ERK1/2,(B) p-GATA4 at Ser105, and (D) p-STAT3 at Tyr705 and Ser727 expression were detected by western blotting; the transcriptional activities of (C) GATA4 and (E) STAT3 were measured using a luciferase reporter assay; the mRNA levels of (F) ANF and BNP as well as (G) cell surface area were measured to assess hypertrophic responses; scale bar = 10 μm. *P < 0.05 versus Con, #P < 0.05 versus 4-CMTB.

    Fig. 8 The effects of TUG-1375 on GATA4 and STAT3 function as well as cardiomyocyte hypertrophy are impaired by MAPK-ERK1/2 pathway inhibition.NRCMs were stimulated with or without TUG-1375 (10 μmol/L) and simultaneously treated with or without U0126 (10 μmol/L) for 24 h. (A) p-GATA4 at Ser105, and (C) p-STAT3 at Ser727 expression were detected by western blotting; the transcriptional activities of (B) GATA4 and (D) STAT3 were measured using a luciferase reporter assay; the mRNA levels of (E) ANF and BNP as well as (F) cell surface area were measured to assess hypertrophic responses;scale bar = 10 μm. *P < 0.05 versus Con, #P < 0.05 versus 4-CMTB.

    4. Discussion

    Heart failure remains a serious public health challenge, and inhibiting the development or reducing the severity of cardiac hypertrophy is important for the improved prevention and treatment of heart failure. FFA2 is a physiological protein involved in immune responses, insulin secretion, and energy metabolism [10].Additionally, FFA2 has been associated with inflammation [13-15]and lipid accumulation [12], although its exact role in these pathological processes remains uncertain and sometimes contradictory [31,32]. It should be noted that chronic inflammation and disorders of lipid metabolism are often observed during cardiac hypertrophy [1,33]. Therefore, whether FFA2 mediates cardiac hypertrophy aroused our interest. Here we found that FFA2 expression increasedin vitroandin vivoin a cardiomyocyte hypertrophy model (Figs.1 and 2). Specific agonist or FFA2 overexpression with agonist elevatedANFandBNPexpression as well as the cell surface area, ultimately inducing cardiomyocyte hypertrophyin vitro(Fig. 3). Simultaneously,FFA2 overexpression alone could not induce cardiomyocyte hypertrophyin vitro, which was probably due to the lack of natural ligands in culture medium. In addition, we found that the band of FFA2 was obviously shifted up and has a large molecular weight span from 55 kDa to over 180 kDa in western blot analysis, which might be associated with the heavy glycosylation of FFA2 [34]. The glycosylation modification is ubiquitous in GPCRs [35]and can cause the bands to move up significantly in SDS-PAGE electrophoresis [36,37].

    It is intriguing how FFA2 induces cardiac hypertrophy. GATA4 and STAT3 are two key transcription factors implicated in cardiac hypertrophy, and phosphorylation plays important roles in their activation. GATA4 is essential in heart development becauseGATA4knockout caused the death of mice at early embryonic stages [38,39].On the other hand,GATA4transgenic mice showed significant cardiac hypertrophy [40]. Furthermore GATA4 promotes the transcription of hypertrophic genes such asβ-myosin heavy chain,ANF, BNP and so on in response to hypertrophic stimulation [21].Two key phosphorylation sites are responsible for GATA4 activation.The phosphorylation at S105 promotes its DNA binding activity and increases the expression of its target genes; moreover, the phosphorylation at S262 induces interaction with p300 and then result in GATA4 acetylation and activation [21]. We found that 4-CMTB significantly induced phosphorylation of GATA4 at Ser105 as well as its transcriptional activity, which were further reinforced by FFA2 overexpression (Figs. 5A and 5B). Moreover,GATA4knockdown rescued 4-CMTB-induced cardiomyocyte hypertrophy(Figs. 5D and 5E). Similarly, STAT3 is involved in models of cardiac hypertrophy such as pressure overload [41,42]and in Ang II type 1 receptor transgenic mice [43]. Furthermore, cardiomyocytespecificSTAT3transgenic mice showed spontaneous cardiac hypertrophy [44]; conversely, inhibition of STAT3 alleviated cardiac hypertrophy [41,45,46]. It has also been shown that activation of FFA2 increases the phosphorylation of STAT3 at Tyr705 and expression of its target genes [47-49]. The phosphorylation at Tyr705 facilitates its homo/hetero-dimerization and is essential for DNA binding; in addition, STAT3 at Ser727 can be also phosphorylated for obtaining maximal transcriptional activity [20]. In the present study,we found that STAT3 phosphorylation at Tyr705 and Ser727 as well as STAT3 transcriptional activity increased after treatment with 4-CMTB (Figs. 6A and 6B). Moreover, cardiomyocyte hypertrophy induced by 4-CMTB treatment was attenuated bySTAT3knockdown(Figs. 6D and 6E). Hence, abnormal activation of GATA4 and STAT3 appear to participate in FFA2-meditated cardiomyocyte hypertrophy.

    Both GATA4 at Ser105 and STAT3 at Ser727 are phosphorylated by MAPK-ERK1/2 [20,21]. ERK1/2 is a downstream target of FFA2 that can be used to evaluate FFA2 activity [16,50]. We found that U0126, a MAPK-ERK1/2 pathway inhibitor, reduced phosphorylation levels of GATA4 at Ser105 and STAT3 at Tyr705 in 4-CMTB-treated cardiomyocytes (Figs. 7A and 7B). These results indicate that ERK1/2 is likely to mediate the increase in GATA4 and STAT3 transcriptional activity by FFA2. In addition, STAT3 phosphorylation at Tyr705 could not be inhibited by U0126, which indicates this site cannot be phosphorylated by ERK1/2. This post-translational modification of STAT3 might be related to FFA2-mediated release of inflammatory factors such as IL-6 [14,51]and TNF-α [52].

    It is generally considered that the ERK1/2 signaling pathway promotes cardiac hypertrophy. For instance, constitutively ERK1/2 activation in the heart induced cardiac hypertrophy in MEK1(upstream of ERK1/2) transgenic mice [53]. On the contrary, the inhibition of ERK1/2 signaling ameliorated cardiac hypertrophy[30,33]. FFA2 can induce the activation of ERK1/2 through both Giand Gqsignaling, but Gqpathway might be predominant [50].Furthermore, ERK1/2 autophosphorylation at Thr188 site via Gqsignaling triggered its nuclear localization and phosphorylation of target proteins and then promoted cardiac hypertrophy. Therefore, it is a possible way for the activation of GATA4 and STAT3 induced by FFA2 via ERK1/2. However, the inhibition of ERK1/2 by U0126 could not completely abolish the hypertrophy induced by FFA2, as did the knockdown of GATA4 or STAT3, which indicated that other pathways such as Ca2+-mediated signaling and PKC [54]might were involved in this pathological process.

    It should be noted that although short-chain fatty acids (SCFAs)such as acetate, butyrate, and propionate are natural ligands for FFA2, SCFAs can exert their functions via both FFA2-dependent and independent mechanisms. For example, SCFAs can activate FFA3 or enter the cytoplasm to inhibit histone deacetylase [55,56]and SIRT3 [57], which might lead to inconsistent results; so high selective agonists are needed in the study of FFA2. It may be worthy to explore the selective agonists in the natural food.

    In summary, FFA2 might promote cardiomyocyte hypertrophy through activation of STAT3 and GATA4 via ERK1/2. Our results provide new insights into the role of FFA2 in cardiac biology and suggest that further studies of it as a therapeutic target in cardiac hypertrophy and heart failure are warranted. Since FFA2 contains two ligand-binding sites and can couple to different G proteins, and FFA2 is widely involved in the regulation of physiological functions and pathological processes, so further investigation of the specificity of downstream signaling events in different diseases and under different inhibitory conditions are required.

    Conflicts of interest

    The authors declare no conflict of interest.

    Acknowledgments

    This work was supported by the National Natural Science Foundation of China (No. 81760058, 81560059, 81660042,31800891), the Scientific Research Project of Health and Family Planning Commission of Hunan Province (No. C2017025), the Project of Medical and Health Science and Technology of Shaoxing City(No. 2020A13063) and the Startup Fund for Research of Shaoxing University (No. 20205021).

    成人无遮挡网站| 国产亚洲欧美98| 欧美成狂野欧美在线观看| 三级毛片av免费| 熟女少妇亚洲综合色aaa.| 可以在线观看的亚洲视频| 欧美激情久久久久久爽电影| 人人妻人人看人人澡| 淫妇啪啪啪对白视频| 久久久久精品国产欧美久久久| 国产日本99.免费观看| 国产精品影院久久| 全区人妻精品视频| 又粗又爽又猛毛片免费看| 村上凉子中文字幕在线| 午夜福利欧美成人| 国产黄a三级三级三级人| 搡老妇女老女人老熟妇| 成人特级av手机在线观看| 乱人视频在线观看| 国内毛片毛片毛片毛片毛片| 久久6这里有精品| 成人无遮挡网站| 国产精品久久视频播放| 真人一进一出gif抽搐免费| 最新在线观看一区二区三区| 国产美女午夜福利| 狂野欧美白嫩少妇大欣赏| 亚洲精品影视一区二区三区av| 日本免费a在线| 免费高清视频大片| 亚洲国产欧洲综合997久久,| 丰满乱子伦码专区| 精品免费久久久久久久清纯| 免费搜索国产男女视频| 高清毛片免费观看视频网站| 国产麻豆成人av免费视频| 中出人妻视频一区二区| svipshipincom国产片| 国产色爽女视频免费观看| 精品人妻一区二区三区麻豆 | 免费观看人在逋| 欧美av亚洲av综合av国产av| 日韩欧美国产在线观看| 两个人看的免费小视频| 婷婷丁香在线五月| 午夜激情福利司机影院| 中出人妻视频一区二区| 国产精品久久电影中文字幕| 欧美一级a爱片免费观看看| netflix在线观看网站| 免费无遮挡裸体视频| 不卡一级毛片| 欧美又色又爽又黄视频| 久久这里只有精品中国| 欧美午夜高清在线| 国产精品三级大全| 成人午夜高清在线视频| 久久九九热精品免费| 亚洲欧美精品综合久久99| 伊人久久精品亚洲午夜| 99久久精品热视频| 国产精品久久视频播放| 日日夜夜操网爽| 午夜福利高清视频| 亚洲av电影在线进入| 久久久久性生活片| 精品福利观看| 国产av不卡久久| 一级作爱视频免费观看| 欧美乱码精品一区二区三区| 欧美在线黄色| 午夜福利视频1000在线观看| 看黄色毛片网站| 男人舔奶头视频| 久久久精品欧美日韩精品| 欧美色欧美亚洲另类二区| 欧美乱码精品一区二区三区| 亚洲自拍偷在线| 18禁美女被吸乳视频| 欧美极品一区二区三区四区| 三级男女做爰猛烈吃奶摸视频| 久久久久久久久大av| 日本一二三区视频观看| 人人妻人人看人人澡| 日本与韩国留学比较| 少妇裸体淫交视频免费看高清| 成人鲁丝片一二三区免费| 搞女人的毛片| 日韩欧美三级三区| 国内精品久久久久久久电影| 白带黄色成豆腐渣| 天堂动漫精品| 亚洲人与动物交配视频| 成人永久免费在线观看视频| 一进一出好大好爽视频| 亚洲国产色片| 亚洲国产欧美网| 亚洲乱码一区二区免费版| 国产一区二区三区在线臀色熟女| 99热6这里只有精品| 国产精品99久久久久久久久| 91麻豆精品激情在线观看国产| 十八禁人妻一区二区| 在线a可以看的网站| 日韩欧美精品v在线| 18禁美女被吸乳视频| 国产久久久一区二区三区| 午夜两性在线视频| 天天添夜夜摸| svipshipincom国产片| 99视频精品全部免费 在线| 亚洲av免费在线观看| 日韩有码中文字幕| 婷婷亚洲欧美| 国产精品一及| 夜夜夜夜夜久久久久| 天天一区二区日本电影三级| 亚洲精品色激情综合| 在线观看日韩欧美| 欧美不卡视频在线免费观看| 有码 亚洲区| 非洲黑人性xxxx精品又粗又长| 91在线观看av| 91麻豆精品激情在线观看国产| 国产欧美日韩一区二区精品| 特级一级黄色大片| 国产高清视频在线观看网站| 狂野欧美激情性xxxx| 老司机在亚洲福利影院| 国产精品日韩av在线免费观看| 夜夜夜夜夜久久久久| 亚洲av五月六月丁香网| 国产三级黄色录像| 国产精品 欧美亚洲| 日本黄大片高清| 亚洲国产欧美人成| 狂野欧美激情性xxxx| av天堂中文字幕网| 中文字幕熟女人妻在线| 亚洲avbb在线观看| 国产乱人视频| 99国产精品一区二区蜜桃av| 国产精品一区二区免费欧美| 久久久久久九九精品二区国产| 最近视频中文字幕2019在线8| 国产一区二区在线av高清观看| 精品久久久久久久末码| 国产精品一区二区免费欧美| 一级a爱片免费观看的视频| 嫩草影院入口| 可以在线观看毛片的网站| 日本与韩国留学比较| 最近最新免费中文字幕在线| 国产伦精品一区二区三区四那| 色在线成人网| 欧美色视频一区免费| 香蕉久久夜色| 中文字幕人妻丝袜一区二区| 欧美另类亚洲清纯唯美| 国产高清视频在线播放一区| 久久亚洲真实| 久久久久久久久中文| 一a级毛片在线观看| 国产亚洲av嫩草精品影院| 一区二区三区国产精品乱码| 丰满的人妻完整版| 国产69精品久久久久777片| 欧美不卡视频在线免费观看| 精品久久久久久久毛片微露脸| 精品99又大又爽又粗少妇毛片 | 女人被狂操c到高潮| 国产欧美日韩精品一区二区| 人妻丰满熟妇av一区二区三区| 真人做人爱边吃奶动态| 亚洲人成网站在线播放欧美日韩| 两个人的视频大全免费| 少妇人妻一区二区三区视频| 国产三级黄色录像| 成年人黄色毛片网站| 国产成人啪精品午夜网站| 国产午夜精品论理片| 国产高清视频在线播放一区| 亚洲精品色激情综合| 日本一二三区视频观看| 尤物成人国产欧美一区二区三区| 色老头精品视频在线观看| 亚洲真实伦在线观看| 久久久久久久午夜电影| 午夜精品在线福利| 久久国产精品人妻蜜桃| h日本视频在线播放| 亚洲精品成人久久久久久| 国产精品女同一区二区软件 | 51国产日韩欧美| 欧美激情久久久久久爽电影| 国产一区二区三区在线臀色熟女| 淫妇啪啪啪对白视频| 亚洲国产精品sss在线观看| 国产精华一区二区三区| 又黄又粗又硬又大视频| 成年女人永久免费观看视频| 日韩欧美国产在线观看| 五月伊人婷婷丁香| 精品无人区乱码1区二区| 婷婷精品国产亚洲av| 久久久久久国产a免费观看| 精品久久久久久成人av| 女人高潮潮喷娇喘18禁视频| 久9热在线精品视频| 99国产精品一区二区三区| 亚洲av美国av| 亚洲国产中文字幕在线视频| 大型黄色视频在线免费观看| 桃红色精品国产亚洲av| 欧美不卡视频在线免费观看| 免费看美女性在线毛片视频| 高潮久久久久久久久久久不卡| 97人妻精品一区二区三区麻豆| 禁无遮挡网站| 日韩精品中文字幕看吧| 偷拍熟女少妇极品色| xxx96com| 男人舔女人下体高潮全视频| 亚洲一区高清亚洲精品| 国产免费一级a男人的天堂| 两个人视频免费观看高清| 一级毛片女人18水好多| 国产免费av片在线观看野外av| 三级毛片av免费| 在线观看免费视频日本深夜| 欧美zozozo另类| 美女被艹到高潮喷水动态| 日本 av在线| 老司机午夜十八禁免费视频| 我的老师免费观看完整版| 最近最新中文字幕大全免费视频| 波多野结衣巨乳人妻| 日本五十路高清| 亚洲精品美女久久久久99蜜臀| 波野结衣二区三区在线 | 亚洲av电影在线进入| 欧美黄色片欧美黄色片| 免费大片18禁| 亚洲国产精品sss在线观看| 在线观看美女被高潮喷水网站 | 男人和女人高潮做爰伦理| 国产又黄又爽又无遮挡在线| 国产精品1区2区在线观看.| 黄色女人牲交| 午夜福利在线观看吧| 色尼玛亚洲综合影院| 日本黄色视频三级网站网址| 久久中文看片网| 高清毛片免费观看视频网站| 亚洲人成网站在线播| 欧美+日韩+精品| 亚洲美女黄片视频| 18禁在线播放成人免费| 老司机福利观看| 欧美不卡视频在线免费观看| 男人舔女人下体高潮全视频| 日本 欧美在线| 亚洲精品乱码久久久v下载方式 | 69人妻影院| 国产单亲对白刺激| 成人国产综合亚洲| 男人舔女人下体高潮全视频| 久久6这里有精品| 亚洲中文日韩欧美视频| 久久香蕉国产精品| 国产探花在线观看一区二区| 欧美黑人欧美精品刺激| 亚洲天堂国产精品一区在线| 国产免费av片在线观看野外av| 首页视频小说图片口味搜索| 久久久久亚洲av毛片大全| 久久性视频一级片| 午夜两性在线视频| 欧美在线一区亚洲| 色老头精品视频在线观看| 乱人视频在线观看| 国产亚洲精品综合一区在线观看| 亚洲精品粉嫩美女一区| 中文字幕久久专区| 亚洲熟妇中文字幕五十中出| 最近最新中文字幕大全电影3| 国产不卡一卡二| 99久久精品国产亚洲精品| 麻豆久久精品国产亚洲av| 国产精品久久视频播放| 国产精品98久久久久久宅男小说| 亚洲欧美日韩卡通动漫| 成人高潮视频无遮挡免费网站| 综合色av麻豆| 成人精品一区二区免费| 久久久久久国产a免费观看| 黑人欧美特级aaaaaa片| 亚洲av美国av| 国产在线精品亚洲第一网站| 色吧在线观看| 最新美女视频免费是黄的| 3wmmmm亚洲av在线观看| 精品日产1卡2卡| 日本五十路高清| 精品熟女少妇八av免费久了| 日韩中文字幕欧美一区二区| 男插女下体视频免费在线播放| 一个人看的www免费观看视频| 国产伦人伦偷精品视频| 国产免费男女视频| 制服丝袜大香蕉在线| 成人精品一区二区免费| 综合色av麻豆| 亚洲成av人片在线播放无| 国产黄a三级三级三级人| 国产高清三级在线| 他把我摸到了高潮在线观看| 国产成人啪精品午夜网站| 18禁黄网站禁片免费观看直播| 很黄的视频免费| ponron亚洲| 午夜精品在线福利| 1000部很黄的大片| 亚洲人成电影免费在线| 中文字幕av成人在线电影| 国产精品嫩草影院av在线观看 | 男女那种视频在线观看| 日韩欧美一区二区三区在线观看| 国产久久久一区二区三区| 日韩 欧美 亚洲 中文字幕| www国产在线视频色| 免费看a级黄色片| 非洲黑人性xxxx精品又粗又长| 午夜福利高清视频| 国产中年淑女户外野战色| 国产高潮美女av| 国产亚洲av嫩草精品影院| 熟女电影av网| 亚洲最大成人手机在线| av在线蜜桃| 午夜老司机福利剧场| 波野结衣二区三区在线 | 搡老熟女国产l中国老女人| 国产精品爽爽va在线观看网站| 欧美一级a爱片免费观看看| 97超视频在线观看视频| 久久久久久久亚洲中文字幕 | 给我免费播放毛片高清在线观看| 精品国产超薄肉色丝袜足j| 黄片大片在线免费观看| 国产极品精品免费视频能看的| 男插女下体视频免费在线播放| 亚洲人成网站在线播放欧美日韩| 青草久久国产| 夜夜看夜夜爽夜夜摸| 嫁个100分男人电影在线观看| 九九在线视频观看精品| 国产亚洲av嫩草精品影院| 夜夜看夜夜爽夜夜摸| 一边摸一边抽搐一进一小说| 免费av不卡在线播放| 天天躁日日操中文字幕| 三级男女做爰猛烈吃奶摸视频| 色精品久久人妻99蜜桃| 成人特级黄色片久久久久久久| 嫁个100分男人电影在线观看| 中文亚洲av片在线观看爽| 久久天躁狠狠躁夜夜2o2o| 亚洲av五月六月丁香网| 天天躁日日操中文字幕| 又紧又爽又黄一区二区| 黄片大片在线免费观看| 亚洲成人久久性| 别揉我奶头~嗯~啊~动态视频| 国产高清视频在线播放一区| bbb黄色大片| 好男人电影高清在线观看| 在线免费观看不下载黄p国产 | 日本成人三级电影网站| 中国美女看黄片| 欧美最新免费一区二区三区 | 亚洲av免费高清在线观看| 国产午夜福利久久久久久| 日韩亚洲欧美综合| 两个人的视频大全免费| bbb黄色大片| 精品电影一区二区在线| 美女高潮的动态| 亚洲精品日韩av片在线观看 | 精品电影一区二区在线| 亚洲人成伊人成综合网2020| 美女大奶头视频| 国产97色在线日韩免费| 2021天堂中文幕一二区在线观| 最新在线观看一区二区三区| 男人舔女人下体高潮全视频| 国产又黄又爽又无遮挡在线| 九色成人免费人妻av| 国产伦精品一区二区三区四那| 九九热线精品视视频播放| 亚洲中文日韩欧美视频| 叶爱在线成人免费视频播放| 亚洲国产精品合色在线| 亚洲五月天丁香| 久久香蕉精品热| tocl精华| 精品国内亚洲2022精品成人| a级毛片a级免费在线| 91在线观看av| 成人午夜高清在线视频| 亚洲人成网站在线播放欧美日韩| 在线观看日韩欧美| 村上凉子中文字幕在线| 亚洲不卡免费看| 91麻豆精品激情在线观看国产| 最新美女视频免费是黄的| 亚洲精品美女久久久久99蜜臀| 国产激情偷乱视频一区二区| 极品教师在线免费播放| 亚洲色图av天堂| 午夜福利在线观看吧| 欧美三级亚洲精品| bbb黄色大片| 久久人人精品亚洲av| 人妻久久中文字幕网| 久久99热这里只有精品18| 国产精品一区二区免费欧美| 九九热线精品视视频播放| 国产亚洲精品一区二区www| 亚洲欧美一区二区三区黑人| 99视频精品全部免费 在线| tocl精华| 国产三级在线视频| 久久伊人香网站| 深夜精品福利| 精品久久久久久久人妻蜜臀av| 淫秽高清视频在线观看| www日本在线高清视频| 国模一区二区三区四区视频| 人妻夜夜爽99麻豆av| 热99re8久久精品国产| 精品久久久久久,| 欧美中文综合在线视频| 亚洲av成人av| 韩国av一区二区三区四区| 男女之事视频高清在线观看| 欧美区成人在线视频| 国产淫片久久久久久久久 | av天堂在线播放| 亚洲人成电影免费在线| 身体一侧抽搐| 一个人免费在线观看的高清视频| 夜夜躁狠狠躁天天躁| 免费av毛片视频| 亚洲国产中文字幕在线视频| 精华霜和精华液先用哪个| bbb黄色大片| 国产精品综合久久久久久久免费| 欧美乱色亚洲激情| 久久久国产精品麻豆| 好看av亚洲va欧美ⅴa在| 久久6这里有精品| 亚洲成人免费电影在线观看| 一进一出抽搐动态| 中文字幕人成人乱码亚洲影| 成人18禁在线播放| 国产一区二区激情短视频| 一本综合久久免费| 日韩欧美精品免费久久 | 深夜精品福利| 99久久99久久久精品蜜桃| 欧美激情在线99| 熟女电影av网| 久久久久国内视频| 免费av不卡在线播放| 美女cb高潮喷水在线观看| 嫩草影视91久久| 亚洲成人久久爱视频| 悠悠久久av| 非洲黑人性xxxx精品又粗又长| 午夜福利欧美成人| 久久人妻av系列| 亚洲18禁久久av| 国产亚洲精品综合一区在线观看| 久久久久久久精品吃奶| 我的老师免费观看完整版| 色视频www国产| 男人舔女人下体高潮全视频| 国产又黄又爽又无遮挡在线| 国产免费av片在线观看野外av| 国产精品永久免费网站| 亚洲国产日韩欧美精品在线观看 | av在线天堂中文字幕| 中文字幕高清在线视频| 99精品欧美一区二区三区四区| 欧美国产日韩亚洲一区| 最新中文字幕久久久久| 国产69精品久久久久777片| 国产av在哪里看| 桃色一区二区三区在线观看| 日韩欧美国产一区二区入口| 热99re8久久精品国产| 又粗又爽又猛毛片免费看| 美女 人体艺术 gogo| 神马国产精品三级电影在线观看| 国内精品久久久久久久电影| 人人妻,人人澡人人爽秒播| 国产中年淑女户外野战色| 亚洲真实伦在线观看| 国产69精品久久久久777片| 精品久久久久久,| 中出人妻视频一区二区| 啦啦啦免费观看视频1| 亚洲欧美精品综合久久99| 日韩 欧美 亚洲 中文字幕| 成熟少妇高潮喷水视频| 欧美bdsm另类| 亚洲精品乱码久久久v下载方式 | 色尼玛亚洲综合影院| 亚洲内射少妇av| 成人高潮视频无遮挡免费网站| 国产亚洲精品久久久com| 亚洲真实伦在线观看| 日韩欧美国产在线观看| 99国产综合亚洲精品| 精品不卡国产一区二区三区| 免费在线观看亚洲国产| 国产私拍福利视频在线观看| 香蕉久久夜色| 亚洲最大成人手机在线| 精华霜和精华液先用哪个| 国内精品久久久久精免费| 日本a在线网址| 日本黄大片高清| 亚洲第一欧美日韩一区二区三区| www.999成人在线观看| 无限看片的www在线观看| 午夜免费激情av| 色在线成人网| 国内精品久久久久精免费| 最近最新中文字幕大全免费视频| 国产精品综合久久久久久久免费| 亚洲久久久久久中文字幕| 国产一区二区亚洲精品在线观看| 国产精品98久久久久久宅男小说| 国产中年淑女户外野战色| 色综合亚洲欧美另类图片| 中文字幕高清在线视频| www.www免费av| 亚洲乱码一区二区免费版| 男女那种视频在线观看| 亚洲欧美一区二区三区黑人| 国产高清视频在线播放一区| 国产久久久一区二区三区| 欧美性猛交黑人性爽| 在线观看66精品国产| 97超级碰碰碰精品色视频在线观看| 香蕉av资源在线| 中文资源天堂在线| 男人的好看免费观看在线视频| 日韩欧美精品v在线| 免费观看精品视频网站| 亚洲国产精品成人综合色| 国内精品美女久久久久久| 色综合欧美亚洲国产小说| 国产三级黄色录像| 小说图片视频综合网站| 首页视频小说图片口味搜索| 国产av不卡久久| 亚洲av二区三区四区| 在线看三级毛片| 99精品欧美一区二区三区四区| 亚洲欧美日韩东京热| 麻豆成人午夜福利视频| 国产主播在线观看一区二区| 91在线观看av| tocl精华| 久久这里只有精品中国| 欧美乱码精品一区二区三区| 成年人黄色毛片网站| 在线观看一区二区三区| 18+在线观看网站| 国产亚洲av嫩草精品影院| 久久精品国产自在天天线| 午夜视频国产福利| 桃红色精品国产亚洲av| 3wmmmm亚洲av在线观看| 午夜免费男女啪啪视频观看 | 国产av在哪里看| 国产成人av激情在线播放| 丝袜美腿在线中文| 99国产极品粉嫩在线观看| 淫妇啪啪啪对白视频| 一个人观看的视频www高清免费观看| 国产精品影院久久| 夜夜躁狠狠躁天天躁| 天天躁日日操中文字幕| 午夜影院日韩av| 国产激情欧美一区二区| 亚洲精品久久国产高清桃花| 国产午夜精品久久久久久一区二区三区 | 观看免费一级毛片| а√天堂www在线а√下载| 日韩人妻高清精品专区| 国产又黄又爽又无遮挡在线| 岛国在线免费视频观看| 色尼玛亚洲综合影院| 最近视频中文字幕2019在线8| 欧美日韩黄片免| svipshipincom国产片| 欧美日韩乱码在线| 91字幕亚洲| 99热这里只有是精品50| 嫩草影院入口|